Aditya Kohli Sells 6,000 Shares of HilleVax, Inc. (NASDAQ:HLVX) Stock

HilleVax, Inc. (NASDAQ:HLVXGet Free Report) Director Aditya Kohli sold 6,000 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $17.66, for a total transaction of $105,960.00. Following the completion of the sale, the director now directly owns 819,776 shares of the company’s stock, valued at $14,477,244.16. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Aditya Kohli also recently made the following trade(s):

  • On Wednesday, March 20th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $164,221.00, for a total transaction of $985,326,000.00.
  • On Friday, March 8th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $18.66, for a total transaction of $111,960.00.
  • On Wednesday, March 6th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $18.95, for a total transaction of $113,700.00.
  • On Thursday, February 22nd, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $15.05, for a total transaction of $90,300.00.
  • On Tuesday, February 20th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $14.88, for a total transaction of $89,280.00.
  • On Monday, February 12th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $15.32, for a total transaction of $91,920.00.
  • On Thursday, February 8th, Aditya Kohli sold 8,866 shares of HilleVax stock. The shares were sold at an average price of $14.93, for a total transaction of $132,369.38.

HilleVax Price Performance

NASDAQ HLVX opened at $15.87 on Friday. The company has a 50 day simple moving average of $16.05 and a 200-day simple moving average of $14.40. The company has a debt-to-equity ratio of 0.08, a current ratio of 17.58 and a quick ratio of 17.58. HilleVax, Inc. has a 52-week low of $9.94 and a 52-week high of $20.22.

Institutional Trading of HilleVax

A number of hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of HilleVax by 27.0% in the fourth quarter. Vanguard Group Inc. now owns 1,464,840 shares of the company’s stock worth $23,511,000 after purchasing an additional 310,973 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in HilleVax by 17.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 20,314 shares of the company’s stock worth $326,000 after buying an additional 2,952 shares during the last quarter. American International Group Inc. increased its holdings in HilleVax by 23.0% in the fourth quarter. American International Group Inc. now owns 13,031 shares of the company’s stock worth $209,000 after buying an additional 2,437 shares during the last quarter. Barclays PLC increased its holdings in HilleVax by 526.1% in the fourth quarter. Barclays PLC now owns 39,908 shares of the company’s stock worth $640,000 after buying an additional 33,534 shares during the last quarter. Finally, Voya Investment Management LLC acquired a new position in HilleVax in the fourth quarter worth approximately $166,000. 89.77% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “buy” rating and issued a $28.00 price target on shares of HilleVax in a research report on Thursday.

Read Our Latest Stock Analysis on HLVX

HilleVax Company Profile

(Get Free Report)

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.

Read More

Insider Buying and Selling by Quarter for HilleVax (NASDAQ:HLVX)

Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.